biospatial is a technology company.
biospatial has raised $3.0M across 1 funding round.
biospatial has raised $3.0M in total across 1 funding round.
biospatial has raised $3.0M in total across 1 funding round.
biospatial's investors include Bull City Venture Partners.
biospatial is a healthcare analytics company founded in 2017 and headquartered in Durham, North Carolina, that builds a data platform aggregating over 150 million EMS electronic patient care reports (ePCRs) from thousands of providers across more than 40 US states, growing by 100,000 records daily[1][2][3]. It serves EMS agencies, hospitals, federal government, and behavioral health sectors by combining ePCRs with other healthcare data sources, using proprietary AI and machine learning for normalization, linking, pattern recognition, anomaly detection, and actionable insights like EMS trends, overdose tracking, biosurveillance, and interfacility transfer analysis[1][2][3]. On January 6, 2025, biospatial was acquired by ImageTrend, enhancing integrated data intelligence for emergency services and healthcare to drive faster decisions and better outcomes[2][3].
The platform solves key problems in fragmented healthcare data by enabling real-time analytics, predictive insights, and automated reporting for public and commercial entities, with prior revenue around $1 million and 12 employees[1][2].
biospatial was founded in 2017 in Research Triangle Park, NC, by a team with expertise in leveraging complex datasets, backed early by investors like Bull City Venture Partners and Alerion Ventures[1][3][4]. The idea emerged from recognizing the untapped value in EMS ePCRs—messy, structured/unstructured records from ambulance transports—which the founders aimed to aggregate, standardize, anonymize, and analyze for broader healthcare applications[1][3][4]. Early traction included partnerships with municipalities and Washington, D.C., powering initiatives like CDC opioid overdose studies and state-level COVID-19 tracking, establishing its expansive data network[3]. This groundwork led to the January 2025 acquisition by ImageTrend, a move hailed by biospatial CEO Jon Woodworth as unlocking innovation in emergency data intelligence[2].
biospatial rides the wave of AI-driven healthcare analytics and real-world evidence from EMS data, capitalizing on post-pandemic demand for biosurveillance, opioid crisis tracking, and population health management amid surging emergency service needs[2][3]. Timing aligns with federal initiatives like CDC studies and growing EMS data digitization, where fragmented ePCRs represent a massive untapped asset for predictive insights—biospatial's 150M+ record database positions it as a key enabler[1][3]. Market forces favoring it include healthcare's shift to data-driven decisions, resource constraints in emergency services, and AI advancements in handling unstructured data, influencing the ecosystem by powering public health responses and commercial strategies for hospitals and pharma[2][3].
Post-ImageTrend acquisition, biospatial will likely accelerate platform expansion, integrating deeper with 3,000+ customers across fire, EMS, and hospitals to deliver unified intelligence for systemic challenges like disaster recovery and substance abuse trends[2]. Emerging trends in federated learning, real-time probabilistic data linking, and regulatory pushes for health data interoperability will propel its growth, potentially evolving into a cornerstone for national EMS benchmarks and AI-powered predictive healthcare. This positions the combined entity to transform reactive emergency care into proactive, outcome-focused systems, amplifying biospatial's original mission of faster, informed decisions in a data-rich landscape[2][3].
biospatial has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Series A in March 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2022 | $3.0M Series A | Bull City Venture Partners |